Moat Biotechnology Forms To Develop Novel Mucosal Vaccines for Covid-19 and Beyond: Announces Initial Funding Round and Promising Phase I trial results for Intranasal Covid-19 Vaccine

Moat Biotechnology Forms To Develop Novel Mucosal Vaccines for Covid-19 and Beyond: Announces Initial Funding Round and Promising Phase I trial results for Intranasal Covid-19 Vaccine     OKLAHOMA CITY (Sept. 20, 2022) — Moat Biotechnology Corporation (MoatBio), a new...

19days — till what?

Q&A with Joey Wignarajah, co-founder of Oklahoma’s first venture studio, backed by Cortado Ventures   At Cortado Ventures, we partner with best-in-class operators building a vibrant entrepreneurial ecosystem in our region. We do this because we love being a...